Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Research positions them as tools for metabolic exploration, with FDA approval based on trials involving thousands of participants
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
Proper reconstitution isn't just about dissolving a powder
Refund Policy & Protections Both providers have a 4.1 Patient Protection sub-score on their official review pages, which puts them in a fairly typical range for this category rather than far above the field
